Medprin Medical's 2026 interim net profit reaches 56.58 million yuan, up 19.62% year-on-year

Earnings
โดย Jiemian·Read original
Summary · why it matters

Medprin Medical released its 2026 interim report, with net profit attributable to the parent company of 56.58 million yuan, up 19.62% from the same period last year. Total operating revenue was 190 million yuan, up 20.30% year-on-year, achieving growth for three consecutive years. Net cash inflow from operating activities was 48.20 million yuan, down 14.72% year-on-year. The company's latest asset-liability ratio was 9.97%, gross margin was 78.96%, ROE was 6.97%, and diluted earnings per share was 0.85 yuan.

Impact on stocks 1

Others▲ · 1 stocks
© 2026 MarketDXNews